Jerry Radiopharmaceuticals Tender in USA - 147122683

Procurement Summary

Country: USA

Summary: Jerry Radiopharmaceuticals

Deadline: 18 Aug 2026

Posting Date: 13 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147122683

Document Ref. No.: 36C24126Q0738

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

The Department of Veterans Affairs, Networking Contracting Office (NCO 01) located in West Haven, CT, intends to enter into a sole source procurement with Novartis Pharmaceuticals Corporation for Lu-177 vipivotide tetraxetan (PLUVICTO).
Authority: FAR 8.405-6(a)(1)(i) (items peculiar to one manufacturer), FAR 8.405-6(b) (limited-sources justification), MAS ordering authorities at 41 U.S.C. 152(3) and 40 U.S.C. 501, and GSAM/R 538.7104-3(b) as implemented for MAS sole-source justifications (RFO 8.4).
STATEMENT OF WORK RADIOPHARMACEUTICALS
Lu-177 vipivotide tetraxetan (PLUVICTO) is a radioligand therapeutic agent to perform the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive and metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay taxane-based chemotherapy or have received prior taxane-based chemotherapy.
Radiopharmaceutical preparation and delivery of Lu-177 vipivotide tetraxetan (PLUVICTO) doses performed at contractor facility provided by a board-certified radiopharmacist and delivered to the Nuclear Medicine Service at VA Connecticut Healthcare located at 950 Campbell Ave., West Haven, CT, building one, ground floor. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Personnel assigned by the contractor to perform services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia.
A total of 74 doses of Pluvicto to treat prostate-specific membrane antigen (PSMA)-Positive.
Contractor s employees will deliver to the PET/CT Service and give deliveries directly to the PET Technologist on duty. Delivery personnel will be bonded by the contractor.
The contractor will provide for the placement of one or more telephone delivery order (s) per day for items listed in the Pricing and Cost Schedule, 24...
Notice ID: 36c24126q0738

Department/Ind. Agency: veterans affairs, department of

Sub-tier: veterans affairs, department of

Office: 241-network contract office 01 (36c241)

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Inactive Dates: sep 17, 2026

Inactive Policy: manual

Disclaimer: The deadline date mentioned is tentative and provided for informational purposes only. This notice is a procurement forecast or general procurement plan, and not an active tender. Suppliers are advised to refer to the original documents and contact the issuing authority directly for the official tender release date and further details

Documents

 Tender Notice

Documents.zip